Protocol: Alliance – A151804
Please Note: Below is partial eligibility, for full eligibility requirement’s, please contact GHCI Research Department at (810) 762-8181, (810) 762-8079 and/or (810) 762-8038. Thank you!
- Planning to receive a regimen containing one or more immuno-oncology (IO) therapeutics. Note: Contact GHCI Research Dept., to discuss allowable therapeutic agents.
- Has not previously been treated with CTLA-4, PD-1 or PD-L1 inhibitors.
- Willing and able to provide baseline blood and stool samples.
- Receiving one or more of the allowed therapeutic agents.
- Experienced one or more serious AEs.